Patents by Inventor Thomas Varming

Thomas Varming has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LASER DEVICE
    Publication number: 20240106198
    Abstract: A laser device includes a laser configured to generate laser light and a laser control module configured to receive at least a portion of the laser light generated by the laser, to generate a control signal and to feed the control signal back to the laser for stabilizing the frequency, wherein the laser control module includes a tunable frequency discriminating element which is preferably continuously frequency tunable, and where the laser control module is placed outside the laser cavity.
    Type: Application
    Filed: May 31, 2023
    Publication date: March 28, 2024
    Applicant: NKT PHOTONICS A/S
    Inventors: Jens E. PEDERSEN, Poul VARMING, Christian V. POULSEN, Thomas O. FAGERHØJ, Bjarke GØTH, Henrik SØRENSEN
  • Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
    Publication number: 20080269230
    Abstract: This invention relates to the use of compounds capable of inhibiting the activity of a proton-gated cation channel in the treatment of alleviation of diseases or disorders associated with, or mediated by a drop in extra cellular pH.
    Type: Application
    Filed: September 18, 2007
    Publication date: October 30, 2008
    Applicant: PainCeptor Pharma Corporation
    Inventors: Thomas Varming, Frank Watjen
  • CATION CONDUCTING GABAA RECEPTORS AND THEIR USE
    Publication number: 20080033061
    Abstract: This invention relates to cation conducting GABAA receptors, mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the drug screening methods of the invention.
    Type: Application
    Filed: August 14, 2007
    Publication date: February 7, 2008
    Inventors: Marianne Jensen, Philip Ahring, Thomas Varming
  • Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
    Patent number: 7288653
    Abstract: This invention relates to the use of compounds capable of inhibiting the activity of a proton-gated cation channel in the treatment of alleviation of diseases or disorders associated with, or mediated by a drop in extra cellular pH.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: October 30, 2007
    Assignee: PainCeptor Pharma Corporation
    Inventors: Thomas Varming, Frank Wätjen
  • Cation conducting GABA receptors and their use
    Patent number: 7282344
    Abstract: This invention relates to cation conducting GABAA receptors, mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the drug screening methods of the invention.
    Type: Grant
    Filed: June 4, 2002
    Date of Patent: October 16, 2007
    Assignee: Neurosearch A/S
    Inventors: Marianne Lerbech Jensen, Philip K. Ahring, Thomas Varming
  • Compounds and their use as positive AMPA receptor modulators
    Patent number: 7235548
    Abstract: The invention provides novel compounds represented by the general formula compound represented by the formula: wherein the bond represented by the broken line may be a single, a double bond or absent; and if the bond is absent, then the nitrogen is substituted with a hydrogen and R2; X represents SO2 or C?O or CH2; Y represents —CH(R4)—, —N(R4)— or —N(R4)—CH2—, O; and the meaning of R2, R3, R4, R5, R6, R7, and R8 are as defined in the application The compounds are useful as positive modulators of the AMPA-receptor.
    Type: Grant
    Filed: August 18, 2003
    Date of Patent: June 26, 2007
    Assignee: NeuroSearch A/S
    Inventors: Alex Haaht Gouliaev, Mogens Larsen, Thomas Varming, Claus Mathiesen, Tina Holm Johansen, Jorgen Scheel-Kruger, Gunnar M. Olsen, Elsesbet Ostergaard Nielsen
  • Benzothiazine derivatives, their preparation and use
    Patent number: 7199118
    Abstract: This invention relates to novel benzothiazine derivatives of Formula I useful as modulators of the AMPA sensitive glutamate receptors, pharmaceutical compositions comprising such compounds and their use in therapy.
    Type: Grant
    Filed: October 2, 2002
    Date of Patent: April 3, 2007
    Assignee: NeuroSearch A/S
    Inventors: Alex Haahr Gouliaev, Morgens Larsen, Thomas Varming, Claus Mathiesen, Tina Holm Johansen, Karin Sandager Nielsen, Barbara Hartz, Jorgen Scheel-Kruger
  • Compositions and methods for modulating gated ion channels
    Publication number: 20070004680
    Abstract: The present invention relates to compositions and methods to modulate the activity of gated ion channels.
    Type: Application
    Filed: March 30, 2005
    Publication date: January 4, 2007
    Applicant: PainCeptor Pharma Corporation
    Inventors: Kazimierz Babinski, Walter Szarek, Rahul Vohra, Thomas Varming, Philip Ahring, Tino Joergensen, Gordon Blackburn-Munro
  • Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
    Publication number: 20060079529
    Abstract: This invention relates to the use of compounds capable of inhibiting the activity of a proton-gated cation channel in the treatment of alleviation of diseases or disorders associated with, or mediated by a drop in extra cellular pH.
    Type: Application
    Filed: September 30, 2005
    Publication date: April 13, 2006
    Applicant: PainCeptor Pharma Corporation
    Inventors: Thomas Varming, Frank Watjen
  • Compounds and their use as positive AMPA receptor modulators
    Patent number: 6943159
    Abstract: The invention provides novel compounds represented by general formula (I) wherein the bond represented by the broken line may be a single, double bond or absent; and if the bond is absent, then the nitrogen is substituted with a hydrogen and R2; X represents SO2 or C?O of CH2; Y represents —CH(R4)—, —N(R4)—CH2—, O; and the meaning of R2, R3, R4, R5, R6, R7, and R8 are as defined in the application. The compounds are useful as positive modulators of the AMPA-receptor.
    Type: Grant
    Filed: August 18, 2000
    Date of Patent: September 13, 2005
    Assignee: Neurosearch A/S
    Inventors: Alex Haahr Gouliaev, Mogens Larsen, Thomas Varming, Claus Mathiesen, Tina Holm Johansen, Jørgen Scheel-Krüger, Gunnar M. Olsen, Elsebet Østergaard Nielsen
  • Cation conducting gabaa receptors and their use
    Publication number: 20050049190
    Abstract: This invention relates to cation conducting GABAA receptors, mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the drug screening methods of the invention.
    Type: Application
    Filed: June 4, 2002
    Publication date: March 3, 2005
    Inventors: Marianne Jensen, Philip Ahring, Thomas Varming
  • Novel benzothiazine derivatives, their preparation and use
    Publication number: 20040242571
    Abstract: This invention relates to novel benzothiazine derivatives of Formula I useful as modulators of the AMPA sensitive glutamate receptors, pharmaceutical compositions comprising such compounds and their use in therapy.
    Type: Application
    Filed: March 15, 2004
    Publication date: December 2, 2004
    Inventors: Alex Haahr Gouliaev, Morgens Larsen, Thomas Varming, Claus Mathiesen, Tina Holm Johansen, Karin Sandager Nielsen, Barbara Hartz, Jorgen Scheel-Kruger
  • Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
    Publication number: 20040142936
    Abstract: This invention relates to the use of compounds capable of inhibiting the activity of a proton-gated cation channel in the treatment of alleviation of diseases or disorders associated with, or mediated by a drop in extra cellular pH.
    Type: Application
    Filed: December 18, 2003
    Publication date: July 22, 2004
    Applicant: NeuroSearch A/S
    Inventors: Thomas Varming, Frank Watjen
  • Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
    Patent number: 6727260
    Abstract: This invention relates to the use of compounds capable of inhibiting the activity of a proton-gated cation channel in the treatment of alleviation of diseases or disorders associated with, or mediated by a drop in extra cellular pH.
    Type: Grant
    Filed: November 6, 2001
    Date of Patent: April 27, 2004
    Assignee: Neurosearch A/S
    Inventors: Thomas Varming, Frank Wätjen
  • Novel compounds and their use as positive AMPA receptor modulators
    Publication number: 20040043987
    Abstract: The invention provides novel compounds represented by the general formula 5 compound represented by the formula: 1
    Type: Application
    Filed: August 18, 2003
    Publication date: March 4, 2004
    Applicant: Neurosearch A/S.
    Inventors: Alex Haaht Gouliaev, Mogens Larsen, Thomas Varming, Claus Mathiesen, Tina Holm Johansen, Jorgen Scheel-Kruger, Gunnar M. Olsen, Elsesbet Ostergaard Nielsen
  • Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
    Publication number: 20020058663
    Abstract: This invention relates to the use of compounds capable of inhibiting the activity of a proton-gated cation channel in the treatment or aleviation of diseases or disorders associated with, or mediated by a drop in extracellular pH.
    Type: Application
    Filed: November 6, 2001
    Publication date: May 16, 2002
    Inventors: Thomas Varming, Frank Watjen